A detailed history of New Edge Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, New Edge Advisors, LLC holds 126 shares of VCEL stock, worth $7,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126
Previous 126 -0.0%
Holding current value
$7,402
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$41.71 - $52.9 $4,296 - $5,448
-103 Reduced 44.98%
126 $5,000
Q1 2024

May 14, 2024

SELL
$32.52 - $52.33 $2,016 - $3,244
-62 Reduced 21.31%
229 $11,000
Q4 2023

Feb 13, 2024

BUY
$30.85 - $37.09 $8,977 - $10,793
291 New
291 $10,000
Q2 2021

Jul 22, 2021

SELL
$47.2 - $67.81 $234,725 - $337,219
-4,973 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$30.93 - $59.48 $153,814 - $295,794
4,973 New
4,973 $276,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.77B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.